University of Oregon
uoregon.eduTotal trials
72
Active
19
Phase 3
0
Total enrollment
39,985
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| alpha-FMH | — | — | — | — | — | 1 | |
| Antihistamine | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
Top conditions
- Depression11
- Parenting10
- Parent-Child Relations8
- Health Behavior5
- Substance Use5
- Anxiety5
- Child Behavior4
- Mental Health3
Frequently asked questions about University of Oregon
- How many clinical trials does University of Oregon have on ClinicalTrials.gov?
- University of Oregon is listed as the lead sponsor on 72 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Oregon's trials are in Phase 3?
- 0 of University of Oregon's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does University of Oregon focus on?
- University of Oregon's most-studied conditions on ClinicalTrials.gov are Depression, Parenting, Parent-Child Relations, Health Behavior, Substance Use.
- When are University of Oregon's next clinical trial readouts?
- University of Oregon has 1 upcoming primary-completion readout tracked here; the soonest is “Histamine as a Molecular Transducer of Adaptation to Exercise”, expected around 2025-12-31.